Australian clinicians describe 40 cases of tattoo-associated uveitis

Published on February 18, 2026
The previously rare condition has become a regular fixture of uveitis clinics in Australia – a nation where one in four people have tattoos
Continue reading on website
Other news

Glaukos Reports Fourth Quarter and Full Year 2025 Financial Results

February 18, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, has announced its fourth quarter and full year 2025 financial results. Net sales in the fourth quarter of 2025 climbed to $143.1 million, a 36 percent increase (34 percent in constant curr

Study Finds Wet AMD Poor-responders Need Different Monitoring Approach

February 19, 2026
The above images from the study show representative cases demonstrating distinct patterns of progressive structural deterioration in poor responders to anti-VEGF therapy. Macular atrophy didn’t achieve independent significance in the study. The authors explain that in advanced disease, fibrotic processes may obscure the functional impact of photoreceptor loss caused by macular atrophy. The bottom